Moderna Stock

Moderna Net Margin

The Net Profit Margin of Moderna (MRNA) as of Jul 21, 2026 is -145.16 %. In the previous year, Net Profit Margin was -110.04 % — a change of 31.92% (lower).

Net Margin

-145.16 %

YoY

31.92%

Last updated:

Net Profit Margin of Moderna is 2026 -145.16 % . Net Profit Margin of Moderna was 2025 -110.04 % . It decreases by 31.92% lower compared to the previous year.

Moderna's net margin stands at -145.2%, down from 66.1% several years earlier.

Access this data via the Eulerpool API

Moderna Stock analysis

What does Moderna do? Moderna Inc is a biotechnology company from the USA that specializes in the development of therapies and vaccines based on mRNA technology. The company was founded in 2010 by a group of researchers led by Noubar Afeyan and is headquartered in Cambridge, Massachusetts. Moderna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moderna stock

Net Profit Margin of Moderna is -145.16 % in 2026.

Access this data via the Eulerpool API

Margins — Moderna

All Key Metrics — Moderna